For SARS-CoV-2, the focus is mainly on IgM, IgG, and IgA antibodies that can neutralise the virus by binding to the spike and other membrane proteins and thus preventing infection.11,13 A few studies have focused on the immune response to SARS-CoV-2 infection, especially on the characteristics of adaptive immune response. This evidence concerns the gene CD40LG and infection.